Related references
Note: Only part of the references are listed.Influenza-Associated Aspergillosis Nationwide Trends, Predictors and Outcomes From 2005 to 2014
Aditi Sharma et al.
CHEST (2020)
The global impact ofAspergillusinfection on COPD
Emily E. Hammond et al.
BMC PULMONARY MEDICINE (2020)
Aspergillus fumigatus during COPD exacerbation: a pair-matched retrospective study
Xunliang Tong et al.
BMC PULMONARY MEDICINE (2018)
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Spencer L. G. James et al.
LANCET (2018)
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017
Gregory A. Roth et al.
LANCET (2018)
Acute exacerbations of COPD: risk factors for failure and relapse
Marco Mantero et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2017)
Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015
Joan B. Soriano et al.
LANCET RESPIRATORY MEDICINE (2017)
Clinical outcome and prognostic factors associated with invasive pulmonary aspergillosis: An 11-year follow-up report from Taiwan
Kuo-Shao Sun et al.
PLOS ONE (2017)
Epidemiology of invasive aspergillosis in critically ill patients: clinical presentation, underlying conditions, and outcomes
Fabio Silvio Taccone et al.
CRITICAL CARE (2015)
Importance of Aspergillus spp. isolation in Acute exacerbations of severe COPD: prevalence, factors and follow-up: the FUNGI-COPD study
Arturo Huerta et al.
RESPIRATORY RESEARCH (2014)
Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: a case control study from China
H. Xu et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Delivering cost-effective care for COPD in the USA: recent progress and current challenges
Ian M. Breunig et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2012)
Invasive pulmonary aspergillosis in acute exacerbation of chronic obstructive pulmonary disease and the diagnostic value of combined serological tests
Xiaofang Gao et al.
ANNALS OF SAUDI MEDICINE (2010)
Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome
J. Guinea et al.
CLINICAL MICROBIOLOGY AND INFECTION (2010)
The economic impact of aspergillosis: analysis of hospital expenditures across patient subgroups
Kuo B. Tong et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2009)
Current Concepts: Infection in the Pathogenesis and Course of Chronic Obstructive Pulmonary Disease
Sanjay Sethi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease
JJ Soler-Cataluña et al.
THORAX (2005)
Isolation of Aspergillus spp. from the respiratory tract in critically ill patients:: risk factors, clinical presentation and outcome
J Garnacho-Montero et al.
CRITICAL CARE (2005)
Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease
A Rosell et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Lung aspergillosis.: Role of the corticoids as associated risk factor in the patient with chronic bronchitis
JM Garcés-Jarque et al.
REVISTA CLINICA ESPANOLA (2003)
The clinical spectrum of pulmonary aspergillosis
AO Soubani et al.
CHEST (2002)
Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease
T Seemungal et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Share Paper
